Profil
Peter W.
Letendre served as President, Chief Executive Officer & Director at Pier Pharmaceuticals, Inc. and as a Director at RespireRx Pharmaceuticals, Inc. He was also the Chief Commercial Officer at Replidyne, Inc. from 2005 to 2008.
Letendre received his undergraduate degree in 1980 and his doctorate in 1982 from Massachusetts College of Pharmacy & Health Science.
Anciens postes connus de Peter W. Letendre
| Sociétés | Poste | Fin |
|---|---|---|
Replidyne, Inc.
Replidyne, Inc. BiotechnologyHealth Technology Develops and commercializes novel antibiotics to treat infections caused by drug resistant bacteria | Corporate Officer/Principal | 15/04/2008 |
| RESPIRERX PHARMACEUTICALS INC. | Directeur/Membre du Conseil | - |
Pier Pharmaceuticals, Inc.
Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for sleep apnea | Directeur Général | - |
Formation de Peter W. Letendre
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
RespireRx Pharmaceuticals, Inc.
RespireRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that discovers and develops drug therapies for the treatment of sleep apnea, respiratory depression & other brain-mediated breathing disorders | Health Technology |
Replidyne, Inc.
Replidyne, Inc. BiotechnologyHealth Technology Develops and commercializes novel antibiotics to treat infections caused by drug resistant bacteria | Health Technology |
Massachusetts College of Pharmacy & Health Science
Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pier Pharmaceuticals, Inc.
Pier Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for sleep apnea | Health Technology |
















